Pharmalittle: We’re reading about tariffs increasing U.S. drug costs, Trump cuts on drug safety, and more
Analysis found 25% tariff on pharmaceutical imports would hike U.S. drug costs by nearly $51 billion annually, boosting prices as much as 12.9%
Related Articles
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
Makary told senators that staffing cuts haven’t slowed down the FDA’s core mission.
Merus drug, with immunotherapy, shows preliminary survival boost for patients with head and neck cancer
A Merus drug, combined with Keytruda, shows preliminary survival gains in newly diagnosed metastatic head and neck cancer
In the war for GLP-1 patients, Novo Nordisk leans on telehealth
Novo Nordisk’s limited-time coupon on Wegovy was simultaneously promoted by telehealth companies Ro and Wegovy
I’m a dentist from India. The fluoride debate in the U.S. horrifies me
While debates in the U.S. rage about potential overexposure to fluoride, people worldwide still lack basic access to it.
Reeling from Trump contract cuts, the National Academies prepares for ‘a fairly radical downsizing’
Nation’s leading advisory body on issues of science and technology is “preparing for a fairly radical downsizing.”
I’m a dentist from India. The fluoride debate in the U.S. horrifies me
While debates in the U.S. rage about potential overexposure to fluoride, people worldwide still lack basic access to it.
Open Doors
Open Doors ‘22 is a new civic collaboration that brings together the most creative minds working in health, medicine, and the life sciences.
In its flagship journal, the CDC keeps publishing papers after firing scientists who made the research possible
In its flagship journal, the CDC keeps publishing papers after firing scientists who made the research possible.
Nominate a 2024 STAT Wunderkind
Nominate a 2024 STAT Wunderkind STAT Wunderkinds is a chance to celebrate early-career researchers who are not yet independent scientists or program
Reeling from Trump contract cuts, the National Academies prepares for ‘a fairly radical downsizing’
Nation’s leading advisory body on issues of science and technology is “preparing for a fairly radical downsizing.”